Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.

Saved in:
Bibliographic Details
Title: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Authors: Dos Santos ES; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; Service de Génétique, Institut Curie, Paris, France.; A.C.Camargo Cancer Center, São Paulo, Brazil., Caputo SM; Service de Génétique, Institut Curie, Paris, France., Castera L; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Gendrot M; Service de Génétique, Institut Curie, Paris, France., Briaux A; Service de Génétique, Institut Curie, Paris, France., Breault M; Service de Génétique, Institut Curie, Paris, France., Krieger S; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Rogan PK; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Mucaki EJ; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Burke LJ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Bièche I; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Houdayer C; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Vaur D; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Brown MA; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Lallemand F; Service de Génétique, Institut Curie, Paris, France. francois.lallemand@curie.fr., Rouleau E; Gustave Roussy, Villejuif, France. Etienne.rouleau@gustaveroussy.fr.
Corporate Authors: ENIGMA consortium
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 311-325. Date of Electronic Publication: 2017 Dec 13.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first